Trial in Progress: A Randomized, Open-Label, Phase 3 Study of Axatilimab Versus Best Available Therapy in Patients With Chronic Graft-Versus-Host Disease After ≥2 Prior Lines of Systemic Therapy

Poster Presentation | Jun 12, 2025

Author

Kwon M, et al.

Congress

European Hematology Association Annual Congress 2025

Milan, Italy | June 12 – 15, 2025